You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Article metrics

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

 

Online download statistics by month:

Online download statistics by month: August 2021 to July 2025

AbstractFullPdf
Aug 2021018330
Sep 202107115
Oct 202106815
Nov 202105911
Dec 20210535
Jan 202202610
Feb 202202212
Mar 20220228
Apr 20220265
May 202203014
Jun 202204716
Jul 202202610
Aug 202204310
Sep 20220338
Oct 20220235
Nov 202202818
Dec 20220167
Jan 202302914
Feb 20230302
Mar 20230237
Apr 20230113
May 20230175
Jun 20230195
Jul 2023096
Aug 20230189
Sep 2023073
Oct 20230124
Nov 20230207
Dec 20230205
Jan 20240195
Feb 20240186
Mar 202401223
Apr 202401710
May 20240155
Jun 20240145
Jul 20240246
Aug 20240238
Sep 20240188
Oct 202402510
Nov 202402010
Dec 20240144
Jan 20250246
Feb 20250153
Mar 20250314
Apr 20250434
May 202502911
Jun 20250113
Jul 2025010
Total01364400